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ABSTRACT 
Objective: Mefenamic Acid (MA) is a non-steroidal anti-inflammatory drug (NSAIDs). This drug provides analgesic and antipyretic (fever reducing 
effect) and higher doses, anti-inflammatory effect. This study is focused to develop a rapid and sensitive method for the detection of mefenamic acid 
in human plasma. 
Methods: Protein precipitation technique using acetonitrile was used. Chromatographic separation was achieved on Agilent Zorbax Eclipse XDB-C18 
Results: The recovery was found 83% for MA. The method was validated according to the Centre for Drug Evaluation and Research (CDER) 
guidelines. Calibration plot was linear within the range from 250 to 5000ng ml
(150 mm x 4.6 mm, i. d 3.5 µm) with a mobile phase consisting of acetonitrile and 2% triethylamine (pH was adjusted to 4.2 with phosphoric acid) 
in a ratio of 60:40. The retention time for mefenamic acid and diclofenac was 5.4 and 3.9 minutes respectively. The mefenamic acid was monitored 
at 280 nm using variable-wavelength detector.  
-1 with the coefficient of determination (r2
Conclusion: The results were in compliance with CDER guideline.  
) of ≥ 0.99. The quality 
control samples of mefenamic acid which was termed as low (L), medium (M) and high (H) were analysed to get the precision and accuracy. The 
accuracy for intra-day for L, M and H was 99.71%, 93.8% and 89.52% while for inter day were 97.67%, 93.46% and 91.67% respectively. On the 
other hand, coefficient variance (CV) for intra-day precision for L, M and H was found 2.57%, 2.45% and 1.45% and for inter day CV were 3.11%, 
5.5% and 4.37% respectively. Diclofenac sodium was used as internal standard for this study.  
Keywords: HPLC, Mefenamic Acid, Human plasma, UV detector, Protein precipitation. 
 
INTRODUCTION 
Mefenamic acid (benzoic acid, 2-(2, 3-dimethylphenyl) amino-N-2, 3-
Xylylanthranilic acid) is non-steroidal anti-inflammatory drugs 
(NSAIDs)[1]. Mefenamic acid acts on cyclooxygenase-2 and inhibits 
prostaglandin synthesis. It is used in the treatment of headache, 
dental pain, postoperative and postpartum pain, and many more.  
 
 
Fig. 1: Chemical structure of mefenamic acid 
 
The usual dose of mefenamic acid is 250 – 500 mg given three times 
a day. It is rapidly absorbed after oral administration. Cmax of 
mefenamic acid is 20 µg ml-1
This study was aimed to develop a simple, sensitive, reliable and 
cost effective method for detection and quantitation of mefenamic 
acid in human plasma.  
 and this state can last for 2-4 hour. 
There is several reported study of using HPLC and GC for detecting 
mefenamic acid in human serum and urine. For protein precipitation 
technique [2, 3], according to these methods, retention time for MA 
was longer which was more than 10 minutes. Liquid - liquid 
extraction technique [4-6] required large sample volume, and are 
not very suitable for routine bioanalysis. Besides that, one reported 
study involves multiple extraction which is time consuming. In other 
studies detection of MA in urine [7, 8] involved SPE as extracting 
method. SPE is costly and required large amount of sample.  
MATERIALS AND METHODS  
Chemicals and reagent 
HPLC grade acetonitrile and triethylamine were obtained from 
Fisher scientific, phosphoric acid analytical grade was obtained from 
BDH Darmstadt, Germany. Ultrapure water was taken from Elga 
Purelab Ultra water system. Standard reference material such as 
mefenamic acid, diclofenac sodium, flufenamic acid and 
indomethacin were purchased from Sigma-Aldrich. 
Apparatus 
Agilent 1100 series HPLC system was used for this study which 
consists of degasser, binary pump, auto sampler with Rheodyne 
Technology, column compartment and UV/Vis detector. The whole 
HPLC system was controlled by Agilent Chemstation for LC 3D Rev. 
A. 10.02(1757)  
Chromatographic condition 
The chromatographic separation was performed using Agilent 
Zorbax Eclipse C18 column (150 mm x 4.6 mm, 3.5 µm) with C18 
analytical guard column. The mobile phase consists of acetonitrile 
and 2 % triethylamine adjusted to pH 4.2 with phosphoric acid 
(85%) with ratio of 60:40 (v/v) and was delivered at a flow rate 1 ml 
min-1
Standard solution 
. The solution was filtered using 0.45 µm nylon membrane 
prior to use. CDER guideline was adopted for chromatographic 
method validation [9]. 
Stock solution of 0.1 mg ml-1 mefenamic acid and diclofenac sodium 
(internal standard) was dissolved in acetonitrile. The stock solution 
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was diluted to obtain 0.01 mg ml-1
Extraction procedure 
 of MA and diclofenac sodium and 
used as working standard solution. 
500 µl of spiked standard plasma with mefenamic acid was taken 
into 5 ml glass tube, 4000 ng ml-1diclofenac sodium (IS) was added to 
the spiked plasma. 2 ml of acetonitrile was added to the mixture. The 
samples were vortexed for 30 sec and centrifuged for 5 minutes at 
5000 rpm. The clear supernatant was transferred to another tube and 
evaporated to dryness at 400
Mobile phase composition 
C under stream of nitrogen. The residue 
was reconstituted with 200 µl of mobile phase and used for analysis. 
The mobile phase composition was optimized using acetonitrile and 
combination of several types of buffer in different composition and 
pH adaption in isocratic mode for the mefenamic acid. The 
combination of mobile phase was selected based on the retention 
time factor as well as capability of detection for lower detection.  
Internal standard 
Several compounds were targeted to obtain a clear baseline to serve 
as an internal standard (IS). The compounds were flufenamic acid, 
diclofenac sodium and indomethacin. The compound that showed 
good recovery, better compatibility with the extraction method, and 
shorter analysis time was selected as an internal standard for 
mefenamic acid.  
Selectivity and specificity 
The lack of chromatographic interference at retention times of 
mefenamic acid and IS from endogenous plasma components was 
investigated. Six different batch of human plasma were analysed for 
selectivity and specificity following the optimized chromatographic 
method.  
Calibration 
The spiked plasma containing standard mefenamic acid 250, 500, 
1500, 2500, 3500 and 5000 ng ml-1 was prepared for linearity. 
Calibration curve was prepared by plotting the peak area ratio of 
mefenamic acid and internal standard against the mefenamic acid 
concentration (ng ml-1). The coefficient of determination (r2
Limit of detection and limit of quantitation 
) must 
be 0.99. 
The limit of detection (LOD) is defined as the lowest concentration of 
an analyte in a sample which can be detected but not necessarily 
quantitated as an exact value. A signal to noise ratio of 3:1 is 
considered acceptable for estimating LOD. The limit of quantification 
(LOQ) was the lowest point of the calibration curve which could be 
detected and its best signal to noise ratio is 10:1. 
Precision and accuracy 
Method performance needs to be evaluated using precision and 
accuracy. Precision is defined by the measure of the coefficient of 
variation of the QC samples. The accuracy is defined as the trueness of 
the value of QC sample to the true value. Analysing 6 replicate at four 
different QC levels (LLOQ, L, M, H which was 250 ng, 400 ng, 2700 ng, 
4500 ng respectively) were analysed for intraday precision and 
accuracy. The inter-day precision and accuracy were analysed with 
three replicates at four QC level concentrations on 8 different days.  
Recovery  
The recovery of protein precipitation technique was calculated via 
comparing the response area of the mefenamic acid in spiked plasma 
and its corresponding standard solution and multiply by 100. 
Recovery (%) = [area response of MA in spiked plasma/area 
response of corresponding MA standard] X 100.  
Stability 
The samples were stored at -400
Freeze and thaw stability 
C freezer. The stability of each 
sample was compared with the fresh sample.  
The QC samples were taken from -40oC freezer and thawed 
unassisted at 25o
Short-term temperature stability 
C room temperature. After thawing, the samples 
were re frozen for 12-24 hours. This cycle was repeated three times. 
QC sample (LLOQ, Low, Medium and High) was analyzed until the 
third cycle.  
The QC samples were thawed at room temperature (25o
Long term stability 
C) for 10 
hours and analyzed. 
The QC samples were stored at -40o
RESULTS AND DISCUSSION  
C for 1, 2 and 3 months and 
analyzed.  
Specificity and selectivity 
We demonstrated the absence of interfering endogenous compound 
in blank plasma. Figure 2a showed blank plasma chromatogram. 
Addition of IS in figure 2b showed that they were well separated 
with no interfering peaks. Addition of mefenamic acid with IS (figure 




Fig. 2: Chromatograms obtained from (a) blank plasma (b) 
plasma spiked with 4000 ng ml-1
 
 diclofenac sodium (IS) (c) 
plasma spiked with IS and MA, respectively 
Linearity 
Mefenamic acid was spiked in plasma to obtain the calibration 
standard. 6 calibration points ranging from 250 – 5000ng ml-1 were 
prepared. All calibration point contained 4000ng ml-1 of diclofenac 
sodium (internal standard). The calibration curve was prepared by 
ratio of mefenamic acid and IS (peak area of analyte of mefenamic 
acid/peak area of internal standard). The standard curve was linear 
over the range 250 – 5000 ng ml-1. The standard curve was 
calculated by linear regression method: y = ax + b where y is the 
peak area ratio of drug to an internal standard, a and b are constant, 




Fig. 3: Typical of calibration curve of MA in plasma 
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Limits of detection 
The minimum detectable concentration of mefenamic acid was found 
to be 70 ng ml-1 whereas the quantitative limit (LOQ) was 250ng ml
Method performance of accuracy and precision was evaluated as 
intraday and interday accuracy precision. It was determined by 
replicate analysis of QC samples. The results obtained have been 
listed in Table 1 and 2. These results show good repeatability of the 
method used including both sample processing and 
chromatographic measurement. For intraday, it can be seen that the 
accuracy was perfect and the values were 93.8% - 110.84% whereas 
coefficient of variation (CV) were within 1.45 – 2.57. For interday 
accuracy, it was between 91.67% – 102.69% and for precision which 
is expressed as CV was within 3.11 % - 5.5 %. 
-1 
Accuracy and precision 
Recovery  
Recovery was showed in table 3. The result of the recovery is the 
average of 8 replicates for each concentration. The recovery for all 
the concentration is more than 80 %. 
 







Accuracy, % Accuracy, % 
(LLOQ) 250 110.84 102.69 
(Low) 400 99.71 97.67 
(Medium) 2700 93.80 93.46 
(High) 4500 89.52 91.67 
Relative accuracy {(amount of sample/actual value)*100} 
 




) Intra day 
(n = 8) 
Inter day 
(n = 6) 
Average SD CV Average SD CV 
(LLOQ) 250 277.11 7.03 2.54 256.73 12.52 4.88 
(Low) 400 398.85 10.25 2.57 390.66 97.67 3.11 
(Medium) 2700 2532.65 61.93 2.45 2523.35 138.67 5.5 
(High) 4500 4028.39 58.57 1.45 4125.02 180.12 4.37 
CV {(SD/average)*100} 
 










Table 4: Results of different types of stability samples of MA in plasma. 
Types of stability Percentage of MA concentration %. 
 LLOQ Low Medium High 
1. Short term stability 102.77 96.40 105.53 87.87 
2. Freeze-thaw stability     
a. 1st 92.97  cycle stability 92.07 99.21 94.10 
b. 2nd 89.97  cycle stability 90.63 98.70 95.34 
c. 3rd 91.93  cycle stability 91.67 101.25 94.14 
3. long term stability     
a. 1st 104.13  month 103.85 100.46 95.45 
b. 2nd 87.04  month 94.72 94.43 91.13 
c. 3rd 90.50  month 95.20 90.10 93.35 
 
Stability 
In the present study, the stability of short-term temperature, freeze 
thaw cycle and long term was demonstrated. The degradation of 
mefenamic acid after third freeze thaw cycle was 8%, and for short 
term stability was 1.91% and long term stability after 3 months was 
7.7 %. 
CONCLUSION 
In conclusion, we have developed and validated a simple, sensitive, 
specific and reproducible method for mefenamic acid determination 
in human plasma.  
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